The LLC has played its cards close to the vest. In June, Triangle Business Journal reported that RRT Development purchased ...

“James has more than 30 years of leadership experience in robotics. He has helped forge groundbreaking technological advances at Toyota, Google and Carnegie Mellon University’s Robotics Institute,” ...

Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the appointment of Dr. James Kuffner ...

We are pleased to expand commercial access to QUELIMMUNE and are extremely proud to be the only company to develop and commercialize a therapeutic device that has demonstrated clinical results to ...

A Japanese space startup said its second attempt to launch a rocket carrying small satellites into orbit had been terminated ...

James Kuffner, a pioneer in robotics, has been named the new chief technology officer at Symbotic, a leading developer of warehouse robots.

Launch recap: Scroll down to review live updates from the Monday, Dec. 16, liftoff of a SpaceX Falcon 9 rocket from Cape Canaveral on the secretive RRT-1 mission. Original story: Look for a SpaceX ...

Facing a rough offshore weather forecast, SpaceX has again postponed its latest launch attempt of a Falcon 9 rocket on the RRT-1 mission. Next upcoming try: Monday night. Initially, Space crews ...

Scrub recap: Scroll down for updates from the scrubbed RRT-1 mission on Friday, December 13 from Cape Canaveral. SpaceX, undeterred by superstition, was set for a Friday the 13th launch day.

In older ESRD patients on renal replacement therapy (RRT) with frailty phenotype, the risk of mortality at 1 year is three-times higher compared with ESRD patients without frailty phenotype.